Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Witzig

Showing results (31-40 of 183) with videos related to

Pageof 19
Sort By:
Leukemia|November 26, 2011
Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapyM Gupta, J J Han, M Stenson, et al.
American Journal of Hematology|December 1, 1992
Is persistent polyclonal B lymphocytosis caused by Epstein-Barr virus? A study with polymerase chain reaction and in situ hybridizationK C Chow, J Q Nacilla, T E Witzig, et al.
British Journal of Haematology|February 23, 1999
Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disordersT E Witzig, M Timm, D Larson, et al.
British Journal of Haematology|June 1, 1994
Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myelomaT E Witzig, R A Kyle, W M O'Fallon, et al.
Journal of the American Academy of Dermatology|September 1, 1996
Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatosesC B Harmon, T E Witzig, J A Katzmann, et al.
Leukemia|June 17, 2005
CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlationsS Kumar, S V Rajkumar, T Kimlinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agentsT E Witzig, M Timm, M Stenson, et al.
Leukemia|March 23, 1999
Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myelomaS V Rajkumar, R Fonseca, T E Witzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I study of combined 2-chlorodeoxyadenosine and chlorambucil in chronic lymphoid leukemia and low-grade lymphomaA Tefferi, T E Witzig, J M Reid, et al.
Leukemia & Lymphoma|March 28, 1998
A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphomaT E Witzig, J K Camoriano, G Schroeder, et al.
Pageof 19

Showing results (31-40 of 183) with videos related to

Sort By:
Pageof 19
Leukemia|November 26, 2011
Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapyM Gupta, J J Han, M Stenson, et al.
American Journal of Hematology|December 1, 1992
Is persistent polyclonal B lymphocytosis caused by Epstein-Barr virus? A study with polymerase chain reaction and in situ hybridizationK C Chow, J Q Nacilla, T E Witzig, et al.
British Journal of Haematology|February 23, 1999
Measurement of apoptosis and proliferation of bone marrow plasma cells in patients with plasma cell proliferative disordersT E Witzig, M Timm, D Larson, et al.
British Journal of Haematology|June 1, 1994
Detection of peripheral blood plasma cells as a predictor of disease course in patients with smouldering multiple myelomaT E Witzig, R A Kyle, W M O'Fallon, et al.
Journal of the American Academy of Dermatology|September 1, 1996
Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatosesC B Harmon, T E Witzig, J A Katzmann, et al.
Leukemia|June 17, 2005
CD45 expression by bone marrow plasma cells in multiple myeloma: clinical and biological correlationsS Kumar, S V Rajkumar, T Kimlinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agentsT E Witzig, M Timm, M Stenson, et al.
Leukemia|March 23, 1999
Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myelomaS V Rajkumar, R Fonseca, T E Witzig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I study of combined 2-chlorodeoxyadenosine and chlorambucil in chronic lymphoid leukemia and low-grade lymphomaA Tefferi, T E Witzig, J M Reid, et al.
Leukemia & Lymphoma|March 28, 1998
A phase I trial of high dose ProMACE-CytaBOM with granulocyte colony stimulating factor for patients with non-Hodgkin's lymphomaT E Witzig, J K Camoriano, G Schroeder, et al.
Pageof 19